CAS 2098724-83-3

Abelacimab

CAS : 2098724-83-3

NI-0801 (Anti-CXCL10 / IP-1) is a CHO-expressed humanized monoclonal antibody targeting CXCL10/IP-10 for the study of vitiligo and biliary cirrhosis.

Degré de pureté : 94.9% (SDS-PAGE); 99.1% (SEC-HPLC) - 94.9% (SDS-PAGE); 99.1% (SEC-HPLC)

Couleur et forme : Liquid

Masse moléculaire : 144.32 kDa

Ref: TM-T76894

Abelacimab

CAS : 2098724-83-3

Human monoclonal antibody targeting Factor XI and Factor Xia

Ref: 3D-CLA1526